Prophylaxis against hepatitis B virus recurrence after liver transplantation: A registry study

doi:10.3748/wjg.v21.i2.584

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 21, Issue 2

This Article

Academic Content and Language Evaluation of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (9238)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-2) series, Tables (1-5) series.

Item

Count

PDF

429

WORD

239

HTML

3887

Figures (1-2)

203

Tables (1-5)

204

Sum=4962

Featured Article

The chart showing Browse series, Download series.

Item

Count

Browse

745

Download

1204

Sum=1949

Publishing Process of This Article

Item

Count

Browse

1140

Download

1187

Sum=2327

Jan 14, 2015 (publication date) through Nov 18, 2024

Times Cited of This Article

Times Cited (16)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Retrospective Study

World J Gastroenterol. Jan 14, 2015; 21(2): 584-592
Published online Jan 14, 2015. doi: 10.3748/wjg.v21.i2.584

Open in New Tab Full Size Figure Download Figure

Figure 1 Flow of enrollment of study participants. HBsAg: Hepatitis B surface antigen; LT: Liver transplantation; im: Intramuscular; HBIG: Hepatitis B immunoglobulin; LAM: Lamivudine; ETV: Entecavir; ADV: Adefovir dipivoxil.

Open in New Tab Full Size Figure Download Figure

Figure 2 Cumulative posttransplant survival and hepatitis B virus recurrence rates for each group. A: Cumulative posttransplant survival; B: Cumulative posttransplant hepatitis B virus (HBV) recurrence. HBIG: Hepatitis B immunoglobulin; LAM: Lamivudine; ETV: Entecavir; ADV: Adefovir dipivoxil.

Citation: Shen S, Jiang L, Xiao GQ, Yan LN, Yang JY, Wen TF, Li B, Wang WT, Xu MQ, Wei YG. Prophylaxis against hepatitis B virus recurrence after liver transplantation: A registry study. World J Gastroenterol 2015; 21(2): 584-592
URL: https://www.wjgnet.com/1007-9327/full/v21/i2/584.htm
DOI: https://dx.doi.org/10.3748/wjg.v21.i2.584